Nexvet Biopharma PLC Company Profile (NASDAQ:NVET)

About Nexvet Biopharma PLC

Nexvet Biopharma public limited company is a clinical-stage biopharmaceutical company focused on transforming the therapeutic market for companion animals by developing and commercializing species-specific biologics. The Company's platform technology, which it refers to as PETization, is an algorithmic approach that enables the Company to create monoclonal antibodies (mAbs) a type of biologic, that are designed to be recognized as self or native by an animal's immune system, a property referred to as 100% species-specificity. PETization is designed to build upon the safety and efficacy data from clinically tested human therapies to create new therapies for companion animals. Biologics generally include mAbs, which are targeted antibodies derived from identical (clonal) cells. The Company's advanced product candidates are in pivotal-phase development: ranevetmab (or NV-01) and frunevetmab (or NV-02).

Industry, Sector and Symbol:

Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Exchange: NASDAQ
Symbol: NVET
CUSIP:

Key Metrics:

Previous Close: $4.05
50 Day Moving Average: $4.49
200 Day Moving Average: $4.01
52-Week Range: $2.61 - $6.50
Trailing P/E Ratio: N/A
Foreward P/E Ratio: Infinity
P/E Growth: 0.00
Market Cap: $47.40M
Outstanding Shares: 11,703,000
Beta: 0.49

Profitability:

Return on Equity: -46.46%
Return on Assets: -41.70%

Debt:

Current Ratio: 6.94%
Quick Ratio: 6.94%

Additional Links:

Companies Related to Nexvet Biopharma PLC:

Consensus Ratings for Nexvet Biopharma PLC (NASDAQ:NVET) (?)

Ratings Breakdown:	3 Buy Ratings
Consensus Rating:	Buy (Score: 3.00)
Consensus Price Target:	$11.33 (179.84% upside)

Analysts' Ratings History for Nexvet Biopharma PLC (NASDAQ:NVET)

Show:

Date	Firm	Action	Rating	Price Target
8/16/2016	Credit Suisse Group AG	Reiterated Rating	Buy	$8.00
11/24/2015	Cowen and Company	Reiterated Rating	Buy	$13.00
11/24/2015	Piper Jaffray Cos.	Reiterated Rating	Overweight	$17.00 -> $13.00
3/3/2015	JMP Securities	Initiated Coverage	Outperform	$17.00
3/2/2015	Bank of America Corp.	Initiated Coverage	Buy	$15.00

(Data available from 9/28/2014 forward)

Earnings History for Nexvet Biopharma PLC (NASDAQ:NVET)

Date	Quarter	Consensus Estimate	Actual EPS	Release Link	Conference Call
11/3/2016
9/2/2016		($0.48)	($0.34)	View	N/A
5/12/2016	Q3	($0.44)	($0.50)	View	N/A
11/5/2015		($0.51)	($0.35)	View	N/A
5/8/2015	Q115	($0.40)	($0.36)	View	N/A
3/16/2015		($0.55)	($2.01)	View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Nexvet Biopharma PLC (NASDAQ:NVET)

Current Year EPS Consensus Estimate: $-1.91 EPS

Dividend History for Nexvet Biopharma PLC (NASDAQ:NVET)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Nexvet Biopharma PLC (NASDAQ:NVET)

Insider Ownership Percentage: 37.60%
Institutional Ownership Percentage: 48.82%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
3/4/2016	David Gearing	Insider	Buy	11,113	$3.33	$37,006.29
3/2/2016	Ashraf Hanna	Director	Buy	1,500	$3.20	$4,800.00
2/26/2016	Farallon Capital Management Ll	Insider	Buy	435,000	$3.19	$1,387,650.00
2/24/2016	Cormac G Kilty	Director	Buy	3,000	$3.17	$9,510.00
9/10/2015	Farallon Capital Management Ll	Insider	Buy	11,100	$6.46	$71,706.00
9/9/2015	Cormac G Kilty	Director	Buy	10,000	$4.79	$47,900.00
2/10/2015	One Funds Management Ltd Atf A	Major Shareholder	Buy	100,000	$10.00	$1,000,000.00

(Data available from 1/1/2013 forward)

Latest Headlines for Nexvet Biopharma PLC (NASDAQ:NVET)

Date	Headline
	Nexvet Biopharma Plc Ord (NASDAQ:NVET) Sellers Covered 15.82% of Their Shorts - Post News (NASDAQ:NVET) www.kentuckypostnews.com - September 23 at 6:01 PM
	NEXVET BIOPHARMA PLC Financials (NASDAQ:NVET) finance.yahoo.com - September 7 at 6:39 PM
	Nexvet Biopharma Reports Full Year Fiscal 2016 Results (NASDAQ:NVET) www.publicnow.com - September 2 at 11:21 AM
	NEXVET BIOPHARMA PLC Files SEC form 10-K, Annual Report (NASDAQ:NVET) biz.yahoo.com - September 2 at 11:21 AM
	Q4 2016 Nexvet Biopharma plc Earnings Release - Time Not Supplied (NASDAQ:NVET) biz.yahoo.com - September 2 at 11:21 AM
	NEXVET BIOPHARMA PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi (NASDAQ:NVET) biz.yahoo.com - September 2 at 11:21 AM
	Crowd & Street Monitoring Nexvet Biopharma plc (NASDAQ:NVET) - Post News (NASDAQ:NVET) www.kentuckypostnews.com - August 23 at 6:44 PM
	Will Nexvet Biopharma plc (NASDAQ:NVET) Hit $12 Price Target? - Investor Newswire (NASDAQ:NVET) www.investornewswire.com - August 22 at 11:08 AM
	Is $12 Price Target Attainable For Nexvet Biopharma plc (NASDAQ:NVET)? - Investor Newswire (NASDAQ:NVET) www.investornewswire.com - July 25 at 10:59 AM
	Nexvet Biopharma plc (NASDAQ:NVET): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:NVET) www.engelwooddaily.com - July 22 at 9:30 AM
	Nexvet Biopharma Plc Ord (NASDAQ:NVET) Shorted Shares Increased 32.03% After Market Selling - Consumer Eagle (NASDAQ:NVET) www.consumereagle.com - July 22 at 9:30 AM
	Equity Roundup: Stock Performance Focus on Nexvet Biopharma plc (NASDAQ:NVET) - Press Telegraph (NASDAQ:NVET) presstelegraph.com - July 20 at 9:28 AM
	Nexvet Announces Publication of Two Peer-Reviewed Journal Articles Profiling Frunevetmab (NV-02) and Presentation at the Veterinary Pain Short Course Conference (NASDAQ:NVET) finance.yahoo.com - July 20 at 5:30 AM
	Strong Sell Calls For Nexvet Biopharma plc (NASDAQ:NVET) At 0 - Investor Newswire (NASDAQ:NVET) www.investornewswire.com - July 19 at 6:39 PM
	Nexvet Biopharma plc (NASDAQ:NVET) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:NVET) www.engelwooddaily.com - July 15 at 11:27 AM
	Analyst Target and Average Rating Watch: Nexvet Biopharma plc (NASDAQ:NVET) - Press Telegraph (NASDAQ:NVET) presstelegraph.com - July 14 at 10:07 AM
	Nexvet Biopharma plc (NASDAQ:NVET) Wall Street Analyst Recommendation Outlook - Telanagana Press (NASDAQ:NVET) telanaganapress.com - July 13 at 9:30 AM
	Nexvet Biopharma Plc Ord (NASDAQ:NVET) Short Interest Decreased By 5.62% - Press Telegraph (NASDAQ:NVET) presstelegraph.com - July 13 at 9:30 AM
	Is $12 Within Reach For Nexvet Biopharma plc (NASDAQ:NVET)? - Investor Newswire (NASDAQ:NVET) www.investornewswire.com - July 10 at 5:55 PM
	Company Stock Focus for Nexvet Biopharma plc (NASDAQ:NVET): Which Way Will Shares Head? - Press Telegraph (NASDAQ:NVET) presstelegraph.com - July 8 at 9:30 AM
	Nexvet Biopharma Plc Ord (NASDAQ:NVET) Sellers Covered 5.62% of Their Shorts - Press Telegraph (NASDAQ:NVET) presstelegraph.com - July 8 at 9:30 AM
	Nexvet Biopharma Plc (NVET) Updated Price Targets - FTSE News (NASDAQ:NVET) www.ftsenews.co.uk - July 8 at 9:30 AM
	Broker Outlook For The Week Ahead Nexvet Biopharma Plc (NVET) - Fiscal Standard (NASDAQ:NVET) www.fiscalstandard.com - July 5 at 6:19 PM
	Brokers Issue Average Price Target Of 13.00 On Nexvet Biopharma Plc (NVET) - Fiscal Standard (NASDAQ:NVET) www.fiscalstandard.com - July 3 at 10:48 AM
	Covering the Bases on Nexvet Biopharma plc (NASDAQ:NVET): Where is the Stock Going? - Press Telegraph (NASDAQ:NVET) presstelegraph.com - July 1 at 9:20 AM
	Nexvet Biopharma plc (NASDAQ:NVET) Earnings Glance and Target Price Review - Engelwood Daily (NASDAQ:NVET) www.engelwooddaily.com - July 1 at 9:20 AM
	New Broker Ratings For Nexvet Biopharma Plc (NVET) - FTSE News (NASDAQ:NVET) www.ftsenews.co.uk - July 1 at 9:20 AM
	Nexvet Biopharma Plc Ord (NASDAQ:NVET) Sellers Covered 5.62% of Their Shorts - Engelwood Daily (NASDAQ:NVET) www.engelwooddaily.com - June 27 at 6:27 PM
	Strong Sell Calls Recommendations For Nexvet Biopharma plc (NASDAQ:NVET) At 0 - Investor Newswire (NASDAQ:NVET) www.investornewswire.com - June 26 at 5:45 PM
	Can Nexvet Biopharma plc (NASDAQ:NVET) Meet Analysts Expectations? - Stocks Daily (NASDAQ:NVET) www.stocksdaily.net - June 26 at 5:45 PM
	Recently Issued Stock Ratings For Nexvet Biopharma Plc (NVET) - Fiscal Standard (NASDAQ:NVET) www.fiscalstandard.com - June 25 at 6:05 PM
	Strong Buy Calls Count For Nexvet Biopharma plc (NASDAQ:NVET) At 1 - Investor Newswire (NASDAQ:NVET) www.investornewswire.com - June 20 at 8:10 AM
	This Weeks Broker Views For Nexvet Biopharma Plc (NVET) - Fiscal Standard (NASDAQ:NVET) www.fiscalstandard.com - June 20 at 8:10 AM
	Trend Of Rating Given To Nexvet Biopharma plc (NASDAQ:NVET) - Investor Newswire (NASDAQ:NVET) www.investornewswire.com - June 13 at 9:30 AM
	Nexvet Biopharma PLC :NVET-US: Earnings Analysis: Q3, 2016 By the Numbers : June 10, 2016 (NASDAQ:NVET) www.capitalcube.com - June 10 at 5:02 PM
	Nexvet Biopharma (NVET) Jumps: Stock Moves 9.2% Higher (NASDAQ:NVET) finance.yahoo.com - June 10 at 8:25 AM
	Stock Review and Earnings Check on Nexvet Biopharma plc (NASDAQ:NVET) - HNN (NASDAQ:NVET) hintsnewsnetwork.com - June 3 at 7:01 PM
	Nexvet Biopharma Plc (NVET) Do Brokers Advise Buy, Sell Or Hold? - Share Trading News (NASDAQ:NVET) www.sharetrading.news - June 2 at 9:32 AM
	Target Price and Stock Performance Rundown for Nexvet Biopharma plc (NASDAQ:NVET) - HNN (NASDAQ:NVET) hintsnewsnetwork.com - June 1 at 7:03 PM
	Nexvet Biopharma Plc (NVET) Broker Price Targets For The Coming Week - Share Trading News (NASDAQ:NVET) www.sharetrading.news - May 30 at 9:58 PM
	Earnings Review and Stock Rundown for Nexvet Biopharma plc (NASDAQ:NVET) - Wall Street Hints and News (NASDAQ:NVET) hintsnewsnetwork.com - May 28 at 1:19 PM
	Nexvet Provides Update on Upcoming Investor Symposium at Irish Biomanufacturing Facility (NASDAQ:NVET) www.publicnow.com - May 27 at 5:37 AM
	Latest Analyst Ratings For Nexvet Biopharma Plc (NVET) - Share Trading News (NASDAQ:NVET) www.sharetrading.news - May 26 at 1:24 PM
	Nexvet Biopharma (NVET) Flat on Study Results (NASDAQ:NVET) www.baystreet.ca - May 26 at 1:24 PM
	Nexvet Announces Positive Results from NV-02 Pilot Field Study in Cats with Osteoarthritis (NASDAQ:NVET) www.publicnow.com - May 26 at 5:57 AM
	5:37 am Nexvet Biopharma reports positive results from NV-02 Pilot Field Study; NV-02 Pivotal Study plans underway (NASDAQ:NVET) finance.yahoo.com - May 26 at 5:37 AM
	Q3 2016 Nexvet Biopharma plc Earnings Release - Time Not Supplied (NASDAQ:NVET) biz.yahoo.com - May 12 at 7:07 AM
	Nexvet Reports Financial Results for Third Quarter of Fiscal Year 2016 (NASDAQ:NVET) www.publicnow.com - May 12 at 5:47 AM
	Nexvet to Host Symposium at American College of Veterinary Internal Medicine (ACVIM) Forum to Present Additional NV-01 Pivotal Data in Canine Pain and Clinical Data for NV-02 in Feline Pain (NASDAQ:NVET) www.publicnow.com - May 11 at 6:42 AM
	Nexvet to Host Investor Symposium at its Irish Biomanufacturing Facility (NASDAQ:NVET) www.publicnow.com - May 4 at 6:00 AM